Home
>
National Drug Code (NDC)
>
VFEND
VFEND - 55154-2725-0 - (voriconazole)
Drug Information of VFEND
| Product NDC: | 55154-2725 |
| Proprietary Name: | VFEND |
| Non Proprietary Name: | voriconazole |
| Active Ingredient(s): | 200 mg/1 & nbsp; voriconazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VFEND
| Product NDC: | 55154-2725 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021266 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020524 |
Package Information of VFEND
| Package NDC: | 55154-2725-0 |
| Package Description: | 10 POUCH in 1 BAG (55154-2725-0) > 1 TABLET, FILM COATED in 1 POUCH |
NDC Information of VFEND
| NDC Code | 55154-2725-0 |
| Proprietary Name | VFEND |
| Package Description | 10 POUCH in 1 BAG (55154-2725-0) > 1 TABLET, FILM COATED in 1 POUCH |
| Product NDC | 55154-2725 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | voriconazole |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20020524 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | VORICONAZOLE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
